Position
Chairman
Company
Cagent Vascular
WayneHealthcareHealth CareDescription
Cagent Vascular announced the appointment of Brian Walsh as the new Chief Executive Officer. Brian Walsh, who previously served as Head of Carl Zeiss Meditech Cataract Technology and President and CEO of IanTECH Medical, Inc., brings over 25 years of medical device and health care industry experience in Marketing, Sales, and Executive Leadership to drive the market adoption of Cagent Vascular’ s flagship product, Serranator.
Quick answer
Cagent Vascular Appoints Brian Walsh as Chief Executive Officer (May 7, 2024). Cagent Vascular is based in Wayne, Pennsylvania, United States.
- Who is the new Chairman at Cagent Vascular?
- Cagent Vascular named Brian Walsh Chairman, announced May 7, 2024.
- What did Cagent Vascular announce on May 7, 2024?
- Cagent Vascular announced the appointment of Brian Walsh as the new Chief Executive Officer. Brian Walsh, who previously served as Head of Carl Zeiss Meditech Cataract Technology and President and CEO of IanTECH Medical, Inc., brings over 25 years of medical device and health care industry experience in Marketing, Sales, and Executive Leadership to drive the market adoption of Cagent Vascular’ s flagship product,...
- What does Cagent Vascular do?
- Cagent Vascular has developed and commercialized its novel angioplasty balloon with Serration Technology to treat blocked arteries in the leg or Peripheral Artery Disease (PAD) and Chronic Limb Threatening Ischemia...
- Where is Cagent Vascular based?
- Cagent Vascular is based in Wayne, Pennsylvania, United States.
- Which similar companies made leadership changes around the same time?
- Otolith Labs (May 7, 2024), Peloton (May 9, 2024), Wave Life Sciences (May 9, 2024) and EyePoint, Inc. (May 9, 2024) also announced leadership changes within 45 days of Cagent Vascular.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Health Care
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Otolith Labs Appoints Kevin Franck as Chief Clinical Officer (May 7, 2024)
- Peloton Hires James Marsh as Senior VP & Head of Investor Relations (May 9, 2024)
- Wave Life Sciences Ltd. Appoints Erik Ingelsson, MD, PhD, as Chief Scientific Officer (May 9, 2024)
- EyePoint Pharmaceuticals, Inc. Appoints Isabelle Lefebvre as Chief Regulatory Officer (May 9, 2024)
- Stephen Snyder Appointed as President of CareCloud, Inc. (May 3, 2024)
- Lykos Therapeutics Appoints Allison Rosenthal as Chief Commercial Officer and Coy Stout as Vice President of Market Access (May 3, 2024)
Who to call at Cagent Vascular, and when
A new leader at Cagent Vascular brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Cagent Vascular raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cagent Vascular, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cagent Vascular. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cagent Vascular changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Cagent Vascular changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.